These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 34602072)

  • 1. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management.
    Xu Y; Yang X; Bian H; Xia M
    Lipids Health Dis; 2021 Oct; 20(1):126. PubMed ID: 34602072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.
    Lei HY; Ding YH; Nie K; Dong YM; Xu JH; Yang ML; Liu MQ; Wei L; Nasser MI; Xu LY; Zhu P; Zhao MY
    Biomed Pharmacother; 2021 Jan; 133():111064. PubMed ID: 33378966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
    Fuentes-Prior P
    J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease.
    Jeeyavudeen MS; Chaudhari R; Pappachan JM; Fouda S
    World J Gastroenterol; 2023 Jan; 29(3):487-502. PubMed ID: 36688018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?
    Ferron PJ; Gicquel T; Mégarbane B; Clément B; Fromenty B
    Biochimie; 2020 Dec; 179():266-274. PubMed ID: 32891697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models.
    Egilmezer E; Rawlinson WD
    Rev Med Virol; 2021 Nov; 31(6):e2227. PubMed ID: 33763936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.
    Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J
    Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19.
    Cordeiro A; Ribamar A; Ramalho A
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101807. PubMed ID: 34543756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD.
    Chen H; Chen Q
    Int J Biol Sci; 2022; 18(12):4756-4767. PubMed ID: 35874945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Associated Fatty Liver Disease (MAFLD) and COVID-19 Infection: An Independent Predictor of Poor Disease Outcome?
    Milivojević V; Bogdanović J; Babić I; Todorović N; Ranković I
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629728
    [No Abstract]   [Full Text] [Related]  

  • 11. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity.
    Lamadrid P; Alonso-Peña M; San Segundo D; Arias-Loste M; Crespo J; Lopez-Hoyos M
    Front Immunol; 2021; 12():651728. PubMed ID: 33859644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight.
    Vasques-Monteiro IML; Souza-Mello V
    World J Gastroenterol; 2021 Apr; 27(16):1738-1750. PubMed ID: 33967554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological mechanisms of liver injury in COVID-19.
    Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M
    Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two new and effective food-extracted immunomodulatory agents exhibit anti-inflammatory response activity in the hACE2 acute lung injury murine model of COVID-19.
    Liu S; Wang B; Chen T; Wang H; Liu J; Zhao X; Zhang Y
    Front Immunol; 2024; 15():1374541. PubMed ID: 38807598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19, adaptative immune response and metabolic-associated liver disease.
    Miele L; Napodano C; Cesario A; De Magistris A; Pocino K; Basile U; Rapaccini GL; Gasbarrini A; Grieco A
    Liver Int; 2021 Nov; 41(11):2560-2577. PubMed ID: 34555255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19.
    Brilakis L; Theofilogiannakou E; Lykoudis PM
    World J Gastroenterol; 2024 Mar; 30(11):1480-1487. PubMed ID: 38617460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections at the nexus of metabolic-associated fatty liver disease.
    Boeckmans J; Rombaut M; Demuyser T; Declerck B; Piérard D; Rogiers V; De Kock J; Waumans L; Magerman K; Cartuyvels R; Rummens JL; Rodrigues RM; Vanhaecke T
    Arch Toxicol; 2021 Jul; 95(7):2235-2253. PubMed ID: 34027561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.
    Gao F; Zheng KI; Yan HD; Sun QF; Pan KH; Wang TY; Chen YP; Targher G; Byrne CD; George J; Zheng MH
    Front Endocrinol (Lausanne); 2021; 12():604100. PubMed ID: 33763027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence.
    Buchynskyi M; Kamyshna I; Oksenych V; Zavidniuk N; Kamyshnyi A
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.